Bright Tm-based Downshifting Luminescence Nanoprobe Operating Around 1800 nm for NIR-IIb and C Bioimaging
Overview
Authors
Affiliations
Fluorescence bioimaging based on rare-earth-doped nanocrystals (RENCs) in the shortwave infrared (SWIR, 1000-3000 nm) region has aroused intense interest due to deeper penetration depth and clarity. However, their downshifting emission rarely shows sufficient brightness beyond 1600 nm, especially in NIR-IIc. Here, we present a class of thulium (Tm) self-sensitized RENC fluorescence probes that exhibit bright downshifting luminescence at 1600-2100 nm (NIR-IIb/c) for in vivo bioimaging. An inert shell coating minimizes surface quenching and combines strong cross-relaxation, allowing LiTmF@LiYF NPs to emit these intense downshifting emissions by absorbing NIR photons at 800 nm (large Stokes shift ~1000 nm with a absolute quantum yield of ~14.16%) or 1208 nm (NIR-II and NIR-II). Furthermore, doping with Er for energy trapping achieves four-wavelength NIR irradiation and bright NIR-IIb/c emission. Our results show that Tm-based NPs, as NIR-IIb/c nanoprobes with high signal-to-background ratio and clarity, open new opportunities for future applications and translation into diverse fields.
Li Q, Huang Y, Zhu H, Zhu Y, Yi Y, Li X Adv Sci (Weinh). 2024; 11(44):e2408097.
PMID: 39348236 PMC: 11600275. DOI: 10.1002/advs.202408097.
A Review of Image Sensors Used in Near-Infrared and Shortwave Infrared Fluorescence Imaging.
Zhu B, Jonathan H Sensors (Basel). 2024; 24(11).
PMID: 38894330 PMC: 11175340. DOI: 10.3390/s24113539.
NIR-II light in clinical oncology: opportunities and challenges.
Zhang Z, Du Y, Shi X, Wang K, Qu Q, Liang Q Nat Rev Clin Oncol. 2024; 21(6):449-467.
PMID: 38693335 DOI: 10.1038/s41571-024-00892-0.
Near-Infrared-Responsive Rare Earth Nanoparticles for Optical Imaging and Wireless Phototherapy.
Du P, Wei Y, Liang Y, An R, Liu S, Lei P Adv Sci (Weinh). 2023; 11(8):e2305308.
PMID: 37946706 PMC: 10885668. DOI: 10.1002/advs.202305308.
Wang Q, Zhang X, Tang Y, Xiong Y, Wang X, Li C Pharmaceutics. 2023; 15(8).
PMID: 37631241 PMC: 10457990. DOI: 10.3390/pharmaceutics15082027.